First phase 2 results of autologous tumor-infiltrating lymphocyte (TIL; LN-145) monotherapy in patients with advanced, immune checkpoint inhibitor-treated, non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Schoenfeld, A.; Lee, S.; Paz-Ares, L.; Doger, B.; Gettinger, S.; Haefliger, S.; Orcurto, A.; Sukari, A.; Papa, S.; Moreno, J. F. R.; Finckenstein, F. G.; Jagasia, M.; Fiaz, R.; Sulur, G.; Chen, G.; Gontcharova, V.; He, K. |
| Abstract Title: | First phase 2 results of autologous tumor-infiltrating lymphocyte (TIL; LN-145) monotherapy in patients with advanced, immune checkpoint inhibitor-treated, non-small cell lung cancer (NSCLC) |
| Meeting Title: | 36th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2021) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 9 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2021 Nov 10-14 |
| Meeting Location: | Washington, DC |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2021-11-01 |
| Start Page: | A486 |
| End Page: | A487 |
| Language: | English |
| ACCESSION: | WOS:000774877500440 |
| DOI: | 10.1136/jitc-2021-SITC2021.458 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 458 -- Meeting was also held virtually -- Source: Wos |
